Subscribe to our Daily Digest e-mail

Allergan Patent

9/23/2017

article BLOG: Indian Tribe files Motion to Dismiss RESTASIS Patent Challenge based on Sovereign Immunity
(New York) -- Earlier today the Saint Regis Mohawk Tribe filed a Motion to Dismiss in six[1] separate inter partes review (IPR) proceedings relating to the Allergan drug...
article Native American tribe moves to dismiss Allergan patent case
(New York) -- A Native American tribe holding patents for drugmaker Allergan Plc (AGN.N) on Friday moved to dismiss a case brought by generic drug company Mylan NV...

9/22/2017

article How the Akwesasne Mohawks ended up with the patent for a blockbuster drug
(New York) -- It's been a few weeks since the St. Regis Mohawk Tribe announced a landmark partnership with drug giant Allergan. Allergan, based in Ireland, makes...

9/19/2017

article How A Partnership Between Drug Giant, Native American Tribe, May Affect Drug Patent Challenges
(New York) -- A drug company and a native tribe in upstate New York have struck a deal. They will use the tribe's sovereign status to enhance the patent protection...

9/17/2017

article Allergan seeks tribe’s help in patent dispute
(New York) -- In a novel arrangement, the pharmaceutical maker Allergan has enlisted the Saint Regis Mohawk Tribe to help protect the dry-eye drug Restasis against...
article OP/ED: Allergan patent runaround may be legal, but it's not right
(South Carolina) -- Late last year, at a Forbes magazine health-care conference, I heard Brent Saunders, the chief executive of Allergan, talk about drug prices. He said...

9/16/2017

article To extend a drug patent, one drug company wants to give it to a Native American tribe
(New York) -- It's tough being a pharmaceutical company when your patent rights run out — the generic competition rushes in, and profits go down on a drug that...

9/15/2017

article U.S. senator slams Allergan patent deal with Native-American tribe
(Washington D.C.) -- U.S. Senator Sherrod Brown said on Friday a deal that drugmaker Allergan Plc made with a Native-American tribe to shield patents "rips off consumers...

9/14/2017

article Allergan Avails Itself of Sovereign Immunity
(New York) -- The 11th amendment to the Constitution reads:The judicial power of the United States shall not be construed to extend to any suit in law or equity,...
article Allergan Deal May Set Stage For More Tribal Patent Pacts
(New York) -- A recent deal struck to shield Allergan PLC’s patents for dry eye medication Restasis behind a New York tribe’s sovereign immunity is drawing...
article Mohawks To The Rescue? Can You Immunize Patents From PTAB Review By Assigning To A Native American Tribe?
(New York) -- In an unusual move to combat the perceived bias in favor of patent challengers at the U.S. Patent Office’s Patent Trial and Appeal Board (PTAB), the...
article Tribal justice? A clever new patent transfer strategy seeks to avoid Patent Office scrutiny
(New York) -- “There is a meadow in my perfect world,” goes the haunting poem that opens the gorgeous, disturbing summer film “Wind River,” which concerns a murder on a...

9/13/2017

article Drug company hands patents off to Native American tribe to avoid challenge
(New York) -- A drug company has found a novel way to avoid challenges to some of its most prized patents: handing them off to a Native American tribe for safe-keeping....
article Mylan attacks Allergan over its Mohawk-allied patent strategy — but the CEO is sticking to his guns
(New York) -- Mylan didn’t wait long before challenging Allergan’s bid to safeguard its patents for its blockbuster eye drug Restasis by flipping the rights...
article Tech entity has tribal patent deal similar to Allergan's
(New York) -- The Native American tribe that agreed to hold patents for the drug company Allergan Plc in an attempt to shield them from U.S. administrative review is...

9/12/2017

article HILTZIK: A legal spat between pharmaceutical companies defines what's wrong with our drug regulations
(California) -- Lawsuits in the pharmaceutical industry are as common as TV ads promoting wonder drugs, never mind the horrific side effects relegated to a breathless,...
article More on Tribal Immunity: Is a Tribal-Owned Patent Immune from IPR Challenge?
(Washington D.C.) -- US Law generally holds that Indian Tribes are “Sovereign Powers” that “possess immunity from suit,” although only “to...
article Native American tribe open to more patent deals with pharma
(New York) -- A Native American tribe says it expects more deals with pharma companies looking to protect patents, following a multi-million dollar deal that could...
article U.S. tribal patent deal could have big impact on generic drug market
(New York) -- A groundbreaking deal between Allergan Plc and a Native American tribe to shield the company’s patents in administrative proceedings could also be...
article Why a Drug Company Is Selling Patents to a Native American Tribe
(New York) -- Some especially strange and unprecedented news broke late last week: Drug company Allergan sold the patent for its medication Restasis to the St. Regis...

9/11/2017

article Allergan Pulls A Fast One
(New York) -- Friday brought news of a drug-company maneuver that I had never heard of, and didn’t even realize was possible. First, a bit of background; the stage...
article Allergan's Patent Loophole Could Be a Huge Gift for Pfizer
(New York) -- The tribe has spoken. On Friday, Allergan announced that the Saint Regis Mohawk Tribe now owns all patents for blockbuster dry-eye disease drug Restatis....
article Drug maker ducks patent law by pretending its drugs belong to Mohawk tribe
(New York) -- Corporate titans are adroit at navigating the American legal system to their advantage. When it won’t work to simply outspend their critics and drag...
article St. Regis Mohawk tribe inks landmark deal with drug maker Allergan
(New York) -- The St. Regis Mohawk Tribe here in the North Country is set to receive more than $13 million from the drug-maker Allergan as part of a deal designed to...
article Allergan Patent Deal Isn't Just Unusual. It's Ugly.
(New York) -- Late last year, at a Forbes magazine health-care conference, I heard Brent Saunders, the chief executive of Allergan PLC, talk about drug prices. He said...

9/10/2017

article Allergan Shares Rise on Novel Patent Pact for Restasis
(New York) -- The drugmaker unveiled an agreement that transfers patents for Restasis, Allergan's longstanding dry eye medication, to the Saint Regis Mohawk Tribe,...
article Allergan transfers drug patent to Mohawk tribe to sidestep lawsuits
(New York) -- Drugmaker Allergan announced on Friday that it had transferred its patents on a best-selling eye drug to the Saint Regis Mohawk Tribe in upstate New York...
article Native American tribe gets Allergan drug rights
(New York) -- Allergan has found an unusual way to shield one of its blockbuster drugs from generic competition. The drug giant, which is defending its intellectual...

visionary sponsor advertisement

sponsor advertisement